Fit-for-Purpose Development of the Enabling Route to Crizotinib (PF-02341066)
暂无分享,去创建一个
A. Kamatani | Corey L. Stanchina | P. D. D. Koning | I. B. Moses | P. Rose | Timothy J. Cuthbertson | D. Boyles | Leera T. Rahman | Douglas McAndrew | R. Moore | K. Kissick | Rick Rodriguez | A. Urbina | A. Sandoval | Asayuki Kamatani